Syntekabio Inc (226330) Stock Price & News

226330:KOSDAQ

Syntekabio Inc

₩992.00

-1.29%

(-13.00) 1D

Nov 13, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 226330...

Open

₩1,011

High

₩1,053

Low

₩991

Mkt. cap

24.06B

Avg. vol.

170.70K

Volume

70.84K

52-wk high

₩6,750

52-wk low

₩895

EPS

-₩886

Shares outstanding

24.26M

No. of employees

Open

₩1,011

High

₩1,053

Low

₩991

Mkt. cap

24.06B

Avg. vol.

170.70K

Volume

70.84K

52-wk high

₩6,750

52-wk low

₩895

EPS

-₩886

Shares outstanding

24.26M

No. of employees

Related stocks

Selvas Healthcare Inc

News stories

From web sources and news partners

ChartMill

10 minutes ago

S&P 500 Premarket Movers: Travelers, Palo Alto Networks Gain; Cisco, AMD Fall

Reuters

56 minutes ago

Nasdaq futures subdued as Nvidia upheaval roils AI trade

Trefis

1 hour ago

Nvidia Is 6.1% Of Your S&P 500 Fund. What Is Your Number?

CNBC

2 hours ago

Nasdaq Composite slides as Nvidia shares tumble on Jensen Huang’s exit; oil prices jump

About Syntekabio Inc

CEO-

Employees45

FoundedSep 15, 2009

Headquarters-

SectorHealth Care

Industry-

Websitesyntekabio.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	455.46M	1.76B	422.31M	449.25M
Cost of goods sold	1.33M	-	438.00K	-122.00K
Cost of revenue	1.33M	-	438.00K	-122.00K
Research and development expenses	408.89M	799.59M	1.45B	878.24M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.89B	2.94B	2.08B	1.31B
Operating expense	2.77B	4.25B	3.98B	2.62B
Total operating expenses	2.77B	4.25B	3.98B	2.62B
Operating income	-2.31B	-2.49B	-3.56B	-2.17B
Other non operating income	1.20B	407.81M	463.00M	603.43M
EBT including unusual items	-2.30B	-4.01B	-3.54B	-2.15B
EBT excluding unusual items	-1.64B	-2.92B	-3.48B	-2.03B
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	34.50M	63.02M	18.64M	7.83M
Net income	-2.30B	-4.01B	-3.54B	-2.15B
Net profit margin	-505.71%	-227.85%	-838.93%	-479.35%
Earnings per share	-	-	-	-
Interest and investment income	14.35M	981.00K	118.11M	37.87M
Interest expense	-570.55M	-825.58M	-516.36M	-489.36M
Net interest expenses	-556.20M	-824.60M	-398.25M	-451.49M
Depreciation and amortization charges	408.88M	422.61M	404.67M	399.67M
EBITDA	-1.83B	-1.99B	-3.07B	-1.70B
Gain or loss from assets sale	-	25.27M	-	-

Finance

Ask anything